we find that #TVEC combined with #MEK #inhibitor #binimetinib induced exceptional clinical responses by amplification of pre-existing #Tcell responses and induction of de novo tumor-reactive immunity.
0
0
1
0
we find that #TVEC combined with #MEK #inhibitor #binimetinib induced exceptional clinical responses by amplification of pre-existing #Tcell responses and induction of de novo tumor-reactive immunity.